This suggests that understanding host-pathogen interactions at the level of host genetic susceptibility will allow the formulation of new targeted and patient-tailored antifungal therapeutics, including improved donor screening. 
Introduction
Invasive infections by Aspergillus moulds are associated with high rates of morbidity and mortality, particularly among patients with hematological malignancies, prolonged neutropenia, treated with corticosteroids, or undergoing stem-cell or solid organ transplantation [1] . Although immunocompetent and nonatopic subjects are fairly resistant to Aspergillus infections, A. fumigatus is associated with a wide spectrum of diseases in humans, ranging from allergic syndromes to more severe forms of invasive disease [2] . These considerations imply that only certain host circumstances render the fungus pathogenic or innocuous to the host [3] . As a matter of fact, the exposure to Aspergillus is ubiquitous, and there is no evidence that isolates causing invasive infection are genetically or phenotypically distinct [4] .
The most important risk factor for invasive aspergillosis (IA) has historically been neutropenia. However, it is not clear why some patients with comparable levels of apparent immunocompromise develop disease and others do not. Additionally, stem-cell transplant recipients have reduced rates of neutropenia-related infections and increased frequency of late-onset infections, concomitant with the occurrence of graft-versus-host disease (GVHD) [5) ]. These findings, together with the incidence of aspergillosis in non-neutropenic patients [2, 6] , attest to the importance of specific defects in both innate and adaptive immune mechanisms to the pathogenesis of the infectious process [7] [8] [9] .
Since allogeneic stem-cell transplantation (allo-SCT) dramatically impairs various layers of the immune system, subtle defects in the immune response could become clinically significant. On the contrary, in healthy individuals, the redundancy of the different immune pathways could easily camouflage such immune deficiencies. In this regard, over the last few years, significant advances into the genetic basis of IA occurring in the allo-SCT setting have been made (Table 1) , being now clear that host contributing to different degrees of susceptibility to infection [10] .
The multi-faceted host immune response to Aspergillus fumigatus
Although fungi are not mere passive bystanders in the infectious process, compelling evidence points to the mammalian immune system as the most important determinant of the host-fungus interaction. Host defense mechanisms against Aspergillus are numerous and range from relatively primitive and constitutively expressed non-specific defenses to sophisticated adaptive mechanisms induced specifically during infection [11] . These two arms of the immune system are linked through a variety of cross-regulatory pathways, the integration of which provides for the host the complex arsenal of effector mechanisms for defense.
Among the multiple effector mechanisms of the innate immune system, resident alveolar macrophages have long been recognized as the first line of defense against Aspergillus, preventing hyphal germination and the consequent activation of inflammatory responses against the fungus [12] . In contrast, polymorphonuclear cells (PMNs) are the predominant immune cells in the acute stage of infection. PMNs may act as "double-edged swords", as they are essential for pathogen eradication, but a disproportionate release of oxidants and proteases may also be responsible for injury to the lung [13] . This implies that tight regulatory mechanisms are required to balance protection and immunopathology for efficient control of the fungus.
The innate immune response to fungi is based on a restricted number of receptors, the pattern recognition receptors (PRRs), which play important roles in manipulating the immune response against the fungus, improving or decreasing the intensity of the inflammatory reactions often intended to sterilize the host to avoid infection. Among the signaling PRRs, the Toll-like receptor (TLR) family is [15] [16] [17] [18] . It is of interest that signaling through TLR2 and TLR4 in PMNs is associated with the induction of distinct activation programs, eventually culminating in the occurrence of different patterns of fungal clearance and inflammatory pathology [13, 15] . On the other hand, A. fumigatus is also capable of subverting the host's inflammatory response through the attenuation of TLR2-and TLR4-mediated proinflammatory responses, therefore leading to an immunosuppressive effect eventually facilitating invasiveness [19] .
Although the signaling pathways elicited by TLRs are known to be essential in controlling fungal infection [15] , recent studies have also highlighted the pivotal role of C-type lectin receptors, in particular dectin-1, in the immune response to A. fumigatus [20] . In fact, TLRs and dectin-1, alone or synergistically, can modulate the induction of Th1-and Th17-polarizing cytokines in response to the fungus [21] , demonstrating that the involvement of innate immune receptors other than TLRs may also be required to promote adequate immune responses against A. fumigatus.
TLR4 deficiency triggers paradoxical effects in invasive aspergillosis
There is now undeniable evidence that genetic variants within recognition molecules involved in innate immunity may account, in part, for the inherited differences in human susceptibility to infection [22] . Given the broad effect of TLRs on immunity [14] , their function in human disease has been investigated largely by comparing the incidence of disease among individuals with different polymorphisms in genes that participate in TLR signaling. Accordingly, growing amounts of data suggest that the ability of certain individuals to properly respond to TLR ligands may be impaired by polymorphisms in TLR genes, resulting in an altered susceptibility to, or course of, infectious or [23] . Most studies so far have focused on the highly polymorphic TLR4 gene, in which two co-segregated missense polymorphisms -D299G and T399I -have been described to compromise the extracellular ligand-binding domain of TLR4 [24] . These variants have been linked with blunted airway [25] and systemic inflammatory responses [26] to inhaled lipopolysaccharide (LPS) in adults and attenuated LPS-induced responses in primary airway epithelial cells [25] . Interestingly, the D299G substitution was found to have a greater functional impact compared with the T399I genotype [25] .
One of the first studies investigating the functional consequences of TLR4 polymorphisms in aspergillosis described an increased frequency of the chronic form of pulmonary aspergillosis, chronic cavitary pulmonary aspergillosis (CCPA), among D299G carriers [27] . In CCPA patients, the fungus is able to grow in pre-formed lung cavities, therefore escaping immune surveillance. Considering that subjects harboring the D299G polymorphism have an additional defect in TLR4 function, the increased susceptibility observed is likely due to an extensive impairment in fungal recognition.
Accordingly, Tlr4-deficient mice were also found to be highly susceptible to aspergillosis, in most part due to the inability to effectively clear the fungus [13] .
In the stem-cell transplantation setting, the D299G polymorphism in TLR4 was also found to increase susceptibility to IA in allo-SCT recipients from unrelated donors [28] . The fact that a previous study failed to associate the same donor polymorphism with IA in allo-SCT patients [29] further stresses that the contribution of the D299G polymorphism may depend on the type of transplant and associated clinical variables. In this regard, we have recently described an association between donor D299G and colonization by A. fumigatus, but not invasive disease, in a cohort of T-cell-depleted transplant recipients from related donors [30] . Therefore, fungal colonization may not predict susceptibility to infection in the presence of D299G, at least in this particular fumigatus could be explained by the fact that an abnormal TLR4 extracellular domain could be hampering its function by disrupting microbial recognition, eventually leading to fungal escape from immune surveillance (Fig. 1) . However, TLR4 polymorphisms have also been shown to display a protective effect from hyper-inflammatory diseases, including atherosclerosis and related conditions [31] . Therefore, the failure to recognize the fungus may be compensated by the lack of an exuberant inflammatory response to it which may ultimately be harmful to the host. In this regard, we have found that a hyperinflammatory state, more than the fungus itself, may contribute to susceptibility to aspergillosis and other fungal infections [32] . Thus, by limiting the inflammatory response to the fungus, the D299G polymorphism could contribute to resistance to aspergillosis, despite evidence of fungal growth. Interestingly, the D299G polymorphism was recently shown to have a unique distribution with high prevalence in Africa and low prevalence in Europe, with the authors arguing that the benefit from reduced inflammation during malaria in Africa might have been counter-selected due to lack of inflammation in response to bacterial infections [33] .
Although TLR4 has been representing the cornerstone of genetic variability to aspergillosis in the last few years, polymorphisms in other TLRs have also been linked with susceptibility to Aspergillus. In particular, a common polymorphism in the TLR9 promoter (T-1237C) has been shown to predispose to the allergic form of pulmonary aspergillosis, allergic bronchopulmonary aspergillosis (ABPA) [27] . It is worth mentioning that we found this polymorphism to lead to an increase in TLR9 gene expression in human mononuclear cells that could be further sustained upon TLR9 engagement, presumably resulting in a gain-of-function of the receptor (Rodrigues F, unpublished data). This observation is consistent with a role for TLR9 in response to allergy since Tlr9-deficient mice have been shown to be more resistant to induced [34] . In addition, PMNs from these mice had an increased capacity to kill conidia and damage Aspergillus hyphae [13], therefore arguing for a detrimental role of this TLR9 polymorphism and consequent enhancement of TLR9 function in allergic aspergillosis.
IL-23 and IL-17 have a largely detrimental role in aspergillosis
Despite TLRs being proved to be crucial for detecting infection and activating the innate and adaptive immune systems, sustained TLR stimulation can result in chronic inflammation and is also associated with the development of certain autoimmune diseases [35] . In the last two decades, the immunopathogenesis of aspergillosis and associated inflammatory diseases has been explained primarily in terms of Th1/Th2 balance [11, 36] . Until recently, CD4 + Th1 cells were considered responsible for the development of inflammatory responses to Aspergillus that were mediated by IL-12p70, the key cytokine driving Th1-cell differentiation. The discovery of the IL-12 cytokinefamily member IL-23 has led to a re-evaluation of this conceptual framework [37] . The ability of IL-17 to promote fungal germination further stresses its potential negative role in the immune responses against A. fumigatus [44] . Therefore, the function of the Th17 pathway may go beyond its ability to promote inflammation and subvert antimicrobial immunity by also having a direct action on fungal morphology and virulence. This may translate in concomitant Th2 cell activation, known to be strictly dependent on high levels of hyphal growth [45] , and further prevent Th1 functioning.
Thus, the Th17 pathway may contribute to the pathogenesis of fungal infections, occurring in a fungus-autonomous fashion at sites of infection.
Genetic impairment of IL-23 signaling protects from invasive aspergillosis
Polymorphisms in cytokine genes can influence immune responses and inflammation, thereby affecting susceptibility to aspergillosis in allo-SCT recipients [46] . However, the role of polymorphisms in genes from the IL-23/Th17 inflammatory pathway in were shown to have impaired production of IL-17A compared to wild-type individuals [51] . Interestingly, IL-23 stimulation of highly purified naïve T-cells did not result in any difference whatsoever between R381Q genotypes [51] , suggesting that the consequences of the polymorphism may be exclusively reflected in the function of already differentiated Th17 cells.
In T-cell-depleted allo-SCT recipients, we found that donor R381Q was associated with strong protection from IA and patient R381Q with improved overall survival [47] (Fig. 2) . Strikingly, none of the patients carrying the R381Q polymorphism enrolled in the study developed aspergillosis. These findings are consistent with the protective effects of IL-23 signaling attenuation in experimental aspergillosis [41] . However, a set of polymorphisms in the IL17A and IL17F genes were not associated with susceptibility to IA in allo-SCT recipients [47] , a finding suggesting that further studies are needed to define cellular and molecular mechanisms by which protection from aspergillosis is conferred by the disruption of the IL-23/Th17 axis.
The fact that donor R381Q also increased the risk of cytomegalovirus infection [47] , while being consistent with the enhancing role of IL-23 of antiviral immunity [52] ,
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Immunogenetics: from bench to bedside
Although the dissection of complex genetic traits modulating susceptibility to aspergillosis is complex, the contribution of host genetics may hold the key to elucidate new risk factors for these severe, often fatal diseases. In this sense, new conceptual advances on the knowledge of host immunity need to be accommodated also from an immunogenetic point of view.
It is interesting that the genetic bases for susceptibility to human disease may also be evaluated by the screening of inbred murine strains. Recently, this approach was performed using an immunocompromised mice model of IA [53] . Through a haplotypebased computational genetic analysis of survival data, the gene encoding plasminogen (PLG) was recently identified as a suitable candidate for susceptibility to Aspergillus.
Consequently, a functional polymorphism in human PLG was reported to affect the risk of developing IA in allo-SCT recipients [53] . Besides shedding light into the role of the fibrinolytic system in the pathogenesis of IA, this approach identified a novel, biologically plausible candidate gene, validating its future use in the identification of less obvious disease-related genes.
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